A Phase 1/1b Study to Evaluate the Safety and Tolerability of AB598 Monotherapy and Combination Therapy in Participants With Advanced Malignancies
NCT05891171 · ACTIVE NOT RECRUITING · Phase 1
We track 1 ClinicalTrials.gov studies led by Arcus Biosciences Inc. The portfolio skews toward Phase 1 (1 trials).
1 clinical trials sponsored by Arcus Biosciences Inc.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 1 | 1 | 100% |
Arcus Biosciences Inc currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 1.
Arcus Biosciences Inc conducts research across multiple therapeutic areas. Browse the trial listings for details.
Check the trial listings below for current recruitment status. Trial recruitment status can change frequently.